To main content

PhycoVac – Microalgae-based oral vaccines for aquaculture applications

The project explores microalgae as a platform for next-generation aquaculture vaccines, supporting sustainable disease prevention and improved fish welfare.

Contact persons

Photo: Julia Halang.

Disease outbreaks remain one of the major challenges facing aquaculture and can result in significant economic losses and reduced fish welfare. Although current vaccines are effective, many require individual handling and injection of fish. New approaches are therefore needed to simplify vaccination and support sustainable growth of the aquaculture industry.

PhycoVac investigates the use of microalgae as a production platform for vaccine proteins. Microalgae can be cultivated sustainably and may serve as a foundation for future feed-based vaccination strategies.

SINTEF contributes through genetic engineering and strain development. This includes designing genetic constructs, introducing vaccine genes into microalgae, and developing stable strains capable of producing target vaccine proteins. The project involves laboratory-based research including molecular biology, microalgae cultivation, and protein analysis.

The project has successfully demonstrated production of the vaccine protein VP2 in the marine microalga Nannochloropsis oceanica. This represents an important milestone and confirms the potential of microalgae as hosts for recombinant vaccine production. Future work will focus on increasing protein yield, identifying robust production strains, and preparing the technology for future scale-up and application in aquaculture.

Key facts

Project duration

05/01/2026 - 31/12/2026

Funding

Møre og Romsdal fylkeskommune

Partners